CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands
CTI BioPharma Corp. (CTI) announced today that it has received approval from the Israeli Ministry of Health (MOH) for PIXUVRI® (pixantrone). PIXUVRI in Israel...
UNAIDS issued a report stating that AIDS can be brought under control by 2030
AIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said the number of new...
AIDS can be brought under control by 2030: UNAIDS
AIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said the number of new HIV...
Abbott to sell its developed markets branded generics pharma business to Mylan
The business to be sold operates in Europe, Japan, Canada, Australia and New Zealand and includes approximately 3,800 employees Abbott will sell its developed...
Shire open to AbbVie’s upped offer of £31 billion
AbbVie has now laid on the table a bid of £53.20 a share to acquire UK-headquartered Shire, up from last week’s offer of £51.15....
Glenmark Generics receives final ANDA approval for Telmisartan tablets
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited has been granted final...
Japan Approves- Oral, Interferon and Ribavirin Free Hepatitis C Treatment and others
Offers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to treatment Japanese HCV...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...